News

Recursion Pharmaceuticals, Inc. (RXRX) Description, Stock price, News & Info

By ThinkSabio

#ThinkSabio Latest News

Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas

By ThinkSabio

Related Post

News

Jianzhi Education Technology Group Company Limited (JZ) Stock Price, Latest News, Company Profile & Institutional Holding

ThinkSabio
News

IGC Pharma, Inc. (IGC) Stock Price, Latest News, Company Profile & Institutional Holding

ThinkSabio
News

Cemtrex, Inc. (CETX) Stock Price, Latest News, Company Profile & Institutional Holding

ThinkSabio

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-KFS (12-MAY-2025)

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-THS (12-MAY-2025)

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-TREX (12-MAY-2025)

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-HESM (12-MAY-2025)

Light
Dark